ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

WHO approves Sinopharm vaccine for emergency use

Health body's first greenlight for Chinese-made shot raises hopes for emerging-market access

A health worker holds a dose of Sinopharm's coronavirus vaccine, in Lima, Peru, on Feb. 9.   © Reuters

SHANGHAI -- One of China's COVID-19 vaccines gained crucial recognition Friday, nearly one year after its debut, as the World Health Organization approved the shot for emergency use.

The SARS-CoV-2 vaccine by China National Biotec Group (CNBG) -- a unit of state-owned Sinopharm -- joined five Western peers on the WHO's emergency list.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more